Acta Scientific Microbiology (ISSN: 2581-3226)

Review Article Volume 5 Issue 4

Covid-19 Pandemic and its Variants (Delta and Omicron). Classification, Symptoms, Diagnosis and its Possible Health Impacts Especially on children

Ajaz Rasool1, Jeelani Gousia2 and Baba Uqab3*

1Department of Zoology, University of Kashmir, India

2Centre of Research for Development, University of Kashmir, India

3S P College, Srinagar, India

*Corresponding Author: Baba Uqab, S P College, Srinagar, India.

Received: February 18, 2022; Published: March 16, 2022

Abstract

Covid-19 is continuously sprouting its tentacles in the form of new variants. With genetic instability in virus genomics and structure, Variants of Concern have emerged thick and fast from the original virus. Omicron is the latest of the variants which has emerged out to be the new concern to the health, economics and world order. With 34 mutations in spike protein and 15 in its receptor binding domain alone, Omicron is really a variant of concern. High number of non-synonymous mutations in spike protein has been revealed in omicron variant that are involved in transmissibility, disease severity and immune escape. A total of more than 60 mutations have been reported in omicron variant making it variant with the most mutations sites of all SARS-Cov-2 variants characterized so far. COVID-19's ability to induce long-term consequences was unknown at the start of the epidemic. However, it has been discovered that this is not the case, and people with "long haul COVID-19" might experience a variety of ocular problems.

Keywords:Covid-19; Mutations; Omicron; Ocular Problems

References

  1. Rambaut A., et al. “A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology”. Nature Microbiology 5 (2020): 1403-1407.
  2. Dudas G., et al. “Emergence and spread of SARS-CoV-2 lineage B. 1.620 with variant of concern-like mutations and deletions”. Nature Communications1 (2021): 1-12.
  3. Mathavan S and Kumar S. “Evaluation of the effect of D614G, N501Y and S477N mutation in SARS-CoV-2 through computational approach” (2020).
  4. Kumar S., et al. “Omicron and Delta variant of SARS‐CoV‐2: a comparative computational study of spike protein”. Journal of Medical Virology4 (2021): 1641-1649.
  5. Mahase E. “Delta variant: What is happening with transmission, hospital admissions, and restrictions?” BMJ 373 (2021): n1513.
  6. He X., et al. “SARS‐CoV‐2 Omicron variant: characteristics and prevention”. MedComm4 (2021): 838-845.
  7. Garcia-Beltran W F., et al. “mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant”. Cell 3 (2022).
  8. “Covariants” (2021).
  9. Ren S Y., et al. “Omicron variant (B. 1.1. 529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance”. World Journal of Clinical Cases1 (2022): 1.
  10. Kupferschmidt K and Vogel G. “How bad is Omicron? Some clues are emerging”. Science 6573 (2021): 1304-1305.
  11. Iacobucci, G. “Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show”. BMJ 3103 (2021): n3103.
  12. Tostmann A., et al. “Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020”. Eurosurveillance 16 (2020): 2000508.
  13. Ettaboina S K., et al. “A Mini Review on SARS-COVID-19-2 Omicron Variant (B. 1.1. 529)”. SciMedicine Journal4 (2021): 399-406.
  14. Karim S S A and Karim Q A. “Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic”. The Lancet10317 (2021): 2126-2128.
  15. Blaiszik B., et al. “The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USA”. medRxiv (2021).
  16. Tareq A M., et al. “Impact of SARS-CoV-2 delta variant (B. 1.617. 2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic”. Human Vaccines and Immunotherapeutics11 (2021): 4126-4127.
  17. Bitirgen G., et al. “Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID”. British Journal of Ophthalmology (2021).
  18. “Omicron is sending thousands of children to US hospitals” (2021).
  19. Bittmann S. “Role of Omicron variant of SARS-CoV-2 in children in Germany”. World Journal of Pediatrics (2022): 1-2.
  20. https://www.who.int/health-topics/coronavirus
  21. “US alarm at rise in child COVID infections sees school closures back on agenda” (2021).

Citation

Citation: Baba Uqab., et al. “Covid-19 Pandemic and its Variants (Delta and Omicron). Classification, Symptoms, Diagnosis and its Possible Health Impacts Especially on children". Acta Scientific Microbiology 5.4 (2022): 48-52.

Copyright

Copyright: © 2022 Baba Uqab., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US